Catalyst Pharmaceuticals (CPRX) Return on Equity [ROE] (2011 - 2026)
Catalyst Pharmaceuticals (CPRX) posted Return on Equity [ROE] of 22.50% for Q1 2026, down 3.43 percentage points from 25.93% a year earlier and down 0.36 percentage points from the prior quarter.
Catalyst Pharmaceuticals (CPRX) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Catalyst Pharmaceuticals' Return on Equity [ROE] came in at 25.49%, down 3.90 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a five-year change of -32.81 percentage points (FY2020 to FY2025).
- In prior years, Catalyst Pharmaceuticals' Return on Equity [ROE] was 29.38% in FY2024 (+8.63 pp), 20.75% in FY2023 (-12.01 pp), 32.76% in FY2022 (+11.78 pp) and 20.98% in FY2021 (-37.32 pp).
- The Q1 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q3 2024.
- On a year-over-year basis, Return on Equity [ROE] increased in five of the last eight quarters, with an average year-over-year change of +1.54 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q2 2025, with a gain of 13.64 percentage points; the weakest was Q3 2021, with a drop of 31.90 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was 22.87% (Q4 2025), 24.50% (Q3 2025) and 25.29% (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 1.04 Bn | 134.92 Mn | 22.50% |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 22.50% |
| Dec 31, 2025 | 22.87% |
| Sep 30, 2025 | 24.50% |
| Jun 30, 2025 | 25.29% |
| Mar 31, 2025 | 25.93% |
| Dec 31, 2024 | 23.61% |
| Sep 30, 2024 | 22.49% |
| Jun 30, 2024 | 11.65% |
| Mar 31, 2024 | 13.72% |
| Dec 31, 2023 | 19.39% |
| Sep 30, 2023 | 17.14% |
| Jun 30, 2023 | 32.60% |
| Mar 31, 2023 | 31.35% |
| Dec 31, 2022 | 29.13% |
| Sep 30, 2022 | 26.18% |
| Jun 30, 2022 | 23.63% |
| Mar 31, 2022 | 21.10% |
| Dec 31, 2021 | 19.47% |
| Sep 30, 2021 | 21.47% |
| Jun 30, 2021 | 40.60% |
Catalyst Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CPRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();